Differential antivasoconstrictor effects of levcromakalim and rilmakalim on the isolated human mammary artery and saphenous vein

Journal of Pharmacological Sciences

Volumn 92, Issue 2, 2003, Pages 108-114

  Novaković, Aleksandra ^b   Gojković Bukarica, Ljiljana ^a   Beleslin Čokić, Bojana ^a   Japundžić Žigon, Nina ^a   Sajić, Zoran ^c   Nežić, Dušan ^c   Perić, Miodrag ^c   Djukanović, Boško ^c   Kažić, Tomislav ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Inst of Cardiovasc Dis Dedinje

Author keywords

ATP sensitive K+ channel; Electrical field stimulation; Human vascular bypass graft; Levcromakalim; Rilmakalim

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA ADRENERGIC RECEPTOR; GLIBENCLAMIDE; LEMAKALIM; NORADRENALIN; PHENTOLAMINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; RILMAKALIM; TETRODOTOXIN;

ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; ELECTRIC FIELD; ELECTROSTIMULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; ISOLATED ARTERY; MAMMARY ARTERY; RECEPTOR BLOCKING; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0037630659     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.92.108     Document Type: Article

References (35)

1. Victor MF, Kimbiris D, Iskadrian AS, et al. Spasm of a saphenous vein bypass graft. Chest. 1981;80:413-415.
2. Roubos N, Rosenfeldt FL, Richards SM, Conyers RAJ, Davis BB. Improved preservation of saphenous vein grafts by the use of glyceryl trinitrate-verapamil solution during harvesting. Circulation. 1995;92:31-36.
3. Rosenfeldt FL, He GW, Buxton BF, Angus JA. Pharmacology of coronary artery bypass grafts. Ann Thorac Surg. 1999;67:878-888.
4. He GW, Yang CQ, Starr A. Overview of the nature of vasoconstriction in arterial grafts for coronary operations. Ann Thorac Surg. 1995;59:676-683.
5. Liu MH, Storm Floten H, Furnary AP, Yim AP, He GW. Effects of potassium channel opener aprikalim on the receptor-mediated vasoconstriction in the human internal mammary artery. Ann Thorac Surg. 2001;71:636-641.
6. He GW, Yang CQ. Inhibition of vasoconstriction by potassium channel opener aprikalim in human conduit arteries used as bypass grafts. Br J Clin Pharmacol. 1997;440:353-359.
7. Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, Nelson MT. Hyperpolarizing vasodilatators activate ATP-sensitive channels in arterial smooth muscle. Science. 1989;245:177-180.
8. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1994;268:799-822.
9. Aschcroft SJH, Aschcroft FM. Properties and functions of ATP-sensitive K-channels. Cell Sig. 1990;2:197-214.
10. Bryan J, Aguilar-Bryan L. The ABCs of ATP-sensitive potassium channels: More pieces of the puzzle. Curr Opin Cell Biol. 1997;9:553-559.
11. + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol Cell Physiol. 1998;274:C25-C37.
12. Liss B, Roper J. Molecular physiology of neuronal K-ATP channels. Molecular Membe Biol. 2001;18:117-127.
13. +-channel activators and inhibitors in guinea-pig and human isolated right atrium. Cardiovasc Res. 1999;43:125-134.
14. 86Rb efflux in rat brain cortical slices. J Pharmacol Exp Ther. 1992;263:1296-1301.
15. Gojkovic-Bukarica Lj, Kazic T. Differential effects of pinacidil and levcromakalim on the contractions elicited electrically or by noradrenaline in the portal vein of the rabbit. Fundam Clin Pharmacol. 1999;13:527-534.
16. Docherty JR, Starke K. An examination of the pre- and post-synaptic α-adrenoceptors involved in neuroeffector transmission in rabbit aorta and portal vein. Br J Pharmacol. 1982;76:327-335.
17. + channels. Hypertension. 2000;35:379-384.
18. Bulbring E, Tomita T. Evidence supporting the assumption that the inhibitory potential in the tenia coli of the guinea-pig is a postsynaptic potential due to nerve stimulation. J Physiol (Lond). 1996;185:24-25.
19. + channels. J Physiol (Lond). 1997;499:715-720.
20. Schotborgh C, Wilde A. Sulfonylurea derivates in cardiovascular research and in cardiovascular patients. Cardiovasc Res. 1997;34:73-80.
21. Edwards G, Weston AH. Effects of potassium channel modulating drugs on isolated smooth muscle. In: Szekers L, Papp Gj, editors. Handbook of Experimental Pharmacology. Vol 3. Berlin, Heidelberg, New York: Springer; 1994. p. 469-531.
22. Gojkovic-Bukarica Lj, Kazic T, Sajic Z, Djukanovic B, Panic G, Peric M. The effects of levcromakalim and pinacidil on the human internal mammary artery. Fundam Clin Pharmacol. 1997;11:550-560.
23. ATP channels on nerve terminals of the rat motor cortex. Br J Pharmacol. 1995;115:385-387.
24. Lee K, Dixon AK, Rowe IC, Ashford ML, Richardson PJ. The high-affinity sulphonylurea receptor regulates K (ATP) channels in nerve terminals of the rat motor cortex. J Neurochem. 1996;66:2562-2571.
25. Stanford TM, Lacey MG. Electrophysiological investigation of adenosine triphosphate sensitive potassium channels in rat substantia nigra pars reticulata. Neuroscience. 1997;74:499-509.
26. Watts AE, Hicks GA, Henderson G. Putative pre- and post-synaptic ATP-sensitive potassium channels in the rat substantia nigra in vitro. J Neurosci. 1995;15:3065-3074.
27. Ye GL, Leung KS, Yung WH. Presynaptic effect of the ATP sensitive potassium channel opener diazoxide on rat substantia nigra pars reticulata neurons. Brain Res. 1997; 753:1-7.
28. Meir A, Ginsburg S, Butkevich A, et al. Ion channel in presynaptic nerve terminals and control of transmitter release. Physiol Rev. 1999;79:1019-1088.
29. + channels in the inhibition of rat central adrenergic neurotransmission under hypoxia. Jpn J Pharmacol. 1993;62:279-287.
30. Erne P, Hermsmeyer K. Modulation of intracellular calcium by potassium channel openers in vascular muscle. Naunyn Schmiedebergs Arch Pharmacol. 1991;165:706-715.
31. Greenwood IA, Weston A. Effects of rubidium on responses to potassium openers in rat isolated aorta. Br J Pharmacol. 1993;109:925-932.
32. Itoh T, Seki N, Suzuki S, Ito S, Kajikuri J, Kuriyama H. Membrane hyperpolarization inhibits agonist-induced synthesis of inositol 1,4,5-triphosphate in rabbit mesenteric artery. J Physiol (Lond). 1992;541:307-328.
33. + channel-dependent as well as independent components of pinacidil induced vasodilation. J Pharmacol Exp Ther. 1991;256:492-499.
34. + contracted canine mesenteric artery. Br J Pharmacol. 1990;100:143-149.
35. + channel openers in isolated coronary capillaries. Pflugers Arch. 1998;435:435-438.